PPAG University Announces BCPPS Recertification Credit Opportunities - BEYOND REVIEW! 

Where? During the 25th Annual PPAG Meeting in Atlanta, Georgia
When? April 27-May 1, 2016
What? 10 hours of live, unique, advanced-level specialty sessions dedicated to helping you maintain your BCPPS certification!!

 
 

Session Relevant to your Practice Setting!

You can earn up to ten (10) hours of recertification credit during the Annual Meeting this year. Five (5) hours of NICU and five (5) hours of nutrition/GI will be offered. If you have not done so already, REGISTER TODAY for the Annual Meeting! Click here for a complete schedule.

Recertification Agenda: 

NICU Recertification Sessions

Tales from the Crib: Medication Event Prevention and Error Reduction in the NICU
April 27, 2016 11:30 am – 12:30 pm

Kristin Klein, PharmD, FPPAG
Clinical Associate Professor
University of Michigan, Ann Arbor, Michigan

James Newman
Human Performance Improvement Consultant
Human Performance Tools
Jewett City, Connecticut

At the end of this session, participants will be able to:

  1. Describe the error traps that may contribute to medication prescribing, dispensing, or administering errors in the NICU.
  2. Identify the critical steps in the medication use process where extra diligence may be required to prevent latent or active medication errors.
  3. Weigh the advantages and disadvantages between voluntary medication error reporting processes, and mandatory reporting processes.
  4. Describe at least 4 ways medication errors can be prevented in the NICU.

 

Controversies in Neonatal Drug Therapy
April 27, 2016 2:30 pm – 4:30 pm

Peter Gal, PharmD, BCPS, FPPAG, FACCP,FASHP
Associate Dean for Academic Affairs
High Point University College of Pharmacy
High Point, North Carolina

Sherry Luedtke, PharmD, FPPAG
Associate Professor
Texas Tech Health Science Center School of Pharmacy
Amarillo, Texas

Chris McPherson, PharmD
NICU Clinical Pharmacist
Brigham and Women's Hospital
Boston, Massachusetts

At the end of this session, participants will be able to:

  1. Distinguish the role of emerging therapies for PDA in current practice
  2. Select the optimal intervention for infants with NAS
  3. Identify the advantages and disadvantages of different corticosteroids for the prevention of BPD 
  4. Analyze the risks and benefits of early prophylactic caffeine therapy

 

Pharmacotherapy Inertia in the NICU: Continuing to Use Agents That We Have Always Used
April 28, 2016 10:15 am – 11:15 am

Bob John, PharmD, BCPS
NICU Clinical Pharmacy Specialist
The Children's Hospital at Saint Francis
Tulsa, Oklahoma

Jamie Miller, PharmD, BCPS, BCPPS
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma

At the end of this session, participants will be able to:

  1. Discuss the current role of vitamin A for prevention of CLD in VLBW neonates.
  2. Evaluate the data for and against the use of vitamin A for CLD.
  3. Discuss the current role of phenobarbital for treatment of neonatal seizures
  4. Evaluate the data for and against the use of phenobarbital as a first-line agent for neonatal seizures.

 

Managing Pulmonary Hypertension After iNO Fails
April 28, 2016 11:20 am – 12:20 pm

Alex Oschman, PharmD
Neonatal Intensive Care Unit Clinical Pharmacy Specialist
Children's Mercy Hospital
Kansas City, Missouri

At the end of this session, participants will be able to: 

  1. Differentiate between persistent pulmonary hypertension of the newborn (PPHN) and pulmonary hypertension (PHTN) associated with chronic lung disease (CLD) 
  2. Summarize the 2015 guidelines for treatment of PPHN and PHTN with CLD 
  3. Interpret the evidence available for the use of sildenafil, tadalafil, bosentan, and prostacyclins  
  4. Select drug therapy for pulmonary hypertension based on pros/cons of each option

 

Nutrition/GI Recertification Sessions

Provision of Trace Elements in the Neonate: What the baby really wants
April 30, 2016 10:35 am – 11:05 am

M. Petrea Cober, PharmD, BCNSP
Clinical Coordinator - Neonatal Intensive Care Unit/Associate Professor of Pharmacy Practice
Akron Children's Hospital/Northeast Ohio Medical University, College of Pharmacy
Akron, Ohio

At the end of this session, participants will be able to:

  1. Identify the current ASPEN recommendations for trace element provision in the neonate.
  2. Describe the difficulty in complying with ASPEN recommendations given currently available products and the impact of drug shortages.
  3. Discuss specific recommendations based on various patient populations in the neonatal intensive care unit.

 

Appetite Stimulants in Children
April 30, 2016 11:05 am - 11:35 am

Tracy Hagemann, PharmD, FCCP, FPPAG
Professor and Associate Dean
University of Tennessee College of Pharmacy
Nashville, Tennessee

At the end of this session, participants will be able to:

  1. Describe the suspected causes for appetite suppression and cachexia in children.
  2. Recommend pharmacotherapy for stimulation of appetite in pediatric patients.
  3. Recognize the role that immunomodulary agents may play in pharmacotherapy for appetite stimulation in pediatric patients.

 

The Link Between PN Liver Injury and Fat- Is it the Dose or Type of Oil?
April 30, 2016 1:00 pm – 2:00 pm

Kathleen M. Gura, PharmD, BCNSP, FASHP, FPPAG, FASPEN
Manager, Clinical Research
Boston Children’s Hospital
Boston, Massachusetts

At the end of this session, participants will be able to: 

  1. Understand how the type of oil can influence the therapeutic and physicochemical properties of an IV lipid emulsion  
  2. Describe the effectiveness of restricting conventional lipid emulsions in patients at risk for PN associated liver disease 
  3. List what components are common to all lipid emulsions and how vitamin E and phytosterol content may impact complications associated with different products

 

Constipation: Don’t Poo-Poo It, Clean it Out
May 1, 2016 9:50 am – 10:50 am

Jill A. Morgan, PharmD, BCPS, BCPPS
Associate Professor
University of Maryland School of Pharmacy
Baltimore, Maryland

Allison B. Lardieri, PharmD, BCPPS
Assistant Professor
University of Maryland School of Pharmacy
Baltimore, Maryland

At the end of this session, participants will be able to: 

  1. Formulate a list of pertinent questions to  gather patient histories related to  constipation.  
  2. Given a patient case, develop an appropriate  disimpaction and maintenance treatment  plan.  
  3. Develop patient education and monitoring  plans for patients from infants to adolescents.

 

Issues in Providing Care to Pediatric and Neonatal Patients Receiving Parenteral Nutrition
May 1, 2016 10:55 am -11:55 am

Steve Plogsted, PharmD, BCNSP, CNSC
Nutrition Support Pharmacist
Nationwide Children’s Hospital
Columbus, Ohio

At the end of this session, participants will be able to:

  1. Demonstrate basic pediatric parenteral nutrition order writing skills Discuss complications of long term pediatric parenteral nutrition 
  2. Discuss the impact of parenteral nutrition associated drug shortages on the pediatric patient
  3. Review treatment options of central access catheter associated complications Discuss appropriate markers for monitoring nutritional adequacy
  4. Discuss the need for early parenteral nutrition in the neonate

 

Antimicrobial Stewardship Practices in Intra-abdominal Infections
May 1, 2016 12:05 pm – 1:05 pm

Kristen Nichols, PharmD, BCPPS, BCPS (AQ-ID)
Assistant Professor, Pharmacy Practice
Butler University College of Pharmacy and Health Sciences
Indianapolis, Indiana

Chad Knoderer, PharmD
Associate Professor of Pharmacy Practice
Butler University College of Pharmacy and Health Sciences
Indianapolis, Indiana

At the end of this session, participants will be able to:

  1. List specific ASP targets and interventions to be used in patients with IAI 
  2. Describe benefits and drawbacks to various empiric and targeted antibiotic regimens for IAI 
  3. Identify institutional data and support resources for implementing and sustaining ASP interventions in patients with IAI

 

 

Calendar of Events

Upcoming Webinars

On-Demand Programs

 

Fall Conference